Komori
Zeria Pharmaceutical (4559) · FactFirst stated

Co-founding of Mage Biologics Inc. and application of the equity method

First written in FY2024. . Latest entry: FY2024.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Joint establishment of Mage Biologics Inc. and application of the equity methodA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024First statedAnnual report

    「Tillotts Pharma AG, our consolidated subsidiary, newly established Mage Biologics Inc. through a joint investment with TVM Capital LifeScience. As Mage Biologics Inc. became an affiliate, it has been included in the scope of application of the equity method from the fiscal year under review.」

    Tillotts Pharma AG newly established Mage Biologics Inc. through a joint investment with TVM Capital LifeScience, and Mage Biologics Inc. became an equity-method affiliate from the fiscal year under review.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Zeria Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.